Background: Because of the disturbance in the pituitary gland, growth hormone (GH) secretion will be increased and, as a result, insulin-like growth factor 1 (IGF-1) secretion will be increase as well, leading to a chronic and rare disease called acromegaly disease. One of the most serious complications of acromycaly is diabetes. Insulin resistance, which causes diabetes, occurs in the body because of increased growth hormone secretion Objective: The aim of this work is to estimate some biochemical parameters. These parameters were not studied extensively in the literature such as BALP and LOX and the possibility of using LOX as a new biomarker for acromyalgic patients with diabetic. Patients and Methods: The study was performed on (25) male as patients with active acromegaly and those with type 2 diabetes mellitus, aged between (40-60) years, and (25) male aged between (40-60) years as control group. Blood was collected and serum was separated. Enzyme-linked immune sorbent assay (ELISA) technique was used to determine the GH, IGF-1, BLAP, and LOX. By using enzymatic colorimetric method (Glucose oxidase-peroxidase), fasting serum glucose (FSG) was estimated. MDA and TAC were estimated by colorimetric methods as well. Results: The results showed that there were significant differences among GH, IGF-1, FSG, BLAP, LOX, and MDA when compared between patients and control group, while TAC showed a significant decrease between patients and healthy group (p < 0.05).